PT840750E - Peptido antigenico de ha-2 - Google Patents
Peptido antigenico de ha-2Info
- Publication number
- PT840750E PT840750E PT96911119T PT96911119T PT840750E PT 840750 E PT840750 E PT 840750E PT 96911119 T PT96911119 T PT 96911119T PT 96911119 T PT96911119 T PT 96911119T PT 840750 E PT840750 E PT 840750E
- Authority
- PT
- Portugal
- Prior art keywords
- peptide
- minor
- peptides
- antigen
- bone marrow
- Prior art date
Links
- 230000000890 antigenic effect Effects 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 6
- 239000000427 antigen Substances 0.000 abstract 3
- 102000036639 antigens Human genes 0.000 abstract 3
- 108091007433 antigens Proteins 0.000 abstract 3
- 238000010322 bone marrow transplantation Methods 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 208000009329 Graft vs Host Disease Diseases 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 208000024908 graft versus host disease Diseases 0.000 abstract 1
- 125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 abstract 1
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
- 208000032839 leukemia Diseases 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Transplantation (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP95202039 | 1995-07-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT840750E true PT840750E (pt) | 2006-07-31 |
Family
ID=8220530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT96911119T PT840750E (pt) | 1995-07-25 | 1996-04-25 | Peptido antigenico de ha-2 |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0840750B1 (pt) |
| JP (1) | JPH11514340A (pt) |
| AT (1) | ATE318842T1 (pt) |
| AU (1) | AU716907B2 (pt) |
| CA (1) | CA2224909A1 (pt) |
| DE (1) | DE69635856T2 (pt) |
| DK (1) | DK0840750T3 (pt) |
| ES (1) | ES2259181T3 (pt) |
| NZ (1) | NZ305959A (pt) |
| PT (1) | PT840750E (pt) |
| WO (1) | WO1997005169A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999005174A1 (en) * | 1997-07-23 | 1999-02-04 | Rijksuniversiteit Te Leiden | The ha-1 antigen |
| EP1020519A1 (en) * | 1999-01-15 | 2000-07-19 | Introgene B.V. | Minor histocompatibility antigens and their use in the diagnosis and treatment of tumors |
| EP2110669B1 (en) * | 2002-06-13 | 2011-08-03 | Merck Patent GmbH | Methods for the identification of allo-antigens and their use for cancer therapy and transplantation |
| BR112023021034A2 (pt) * | 2021-04-14 | 2023-12-12 | Tscan Therapeutics Inc | Proteínas de ligação que reconhecem antígeno ha-2 e usos dos mesmos |
-
1996
- 1996-04-25 AU AU54099/96A patent/AU716907B2/en not_active Ceased
- 1996-04-25 CA CA002224909A patent/CA2224909A1/en not_active Abandoned
- 1996-04-25 EP EP96911119A patent/EP0840750B1/en not_active Expired - Lifetime
- 1996-04-25 PT PT96911119T patent/PT840750E/pt unknown
- 1996-04-25 DE DE69635856T patent/DE69635856T2/de not_active Expired - Fee Related
- 1996-04-25 DK DK96911119T patent/DK0840750T3/da active
- 1996-04-25 ES ES96911119T patent/ES2259181T3/es not_active Expired - Lifetime
- 1996-04-25 JP JP9507492A patent/JPH11514340A/ja not_active Ceased
- 1996-04-25 NZ NZ305959A patent/NZ305959A/xx unknown
- 1996-04-25 WO PCT/NL1996/000183 patent/WO1997005169A1/en not_active Ceased
- 1996-04-25 AT AT96911119T patent/ATE318842T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ305959A (en) | 2000-03-27 |
| DE69635856T2 (de) | 2006-11-16 |
| DE69635856D1 (de) | 2006-04-27 |
| AU716907B2 (en) | 2000-03-09 |
| DK0840750T3 (da) | 2006-07-03 |
| CA2224909A1 (en) | 1997-02-13 |
| WO1997005169A1 (en) | 1997-02-13 |
| ES2259181T3 (es) | 2006-09-16 |
| ATE318842T1 (de) | 2006-03-15 |
| EP0840750B1 (en) | 2006-03-01 |
| EP0840750A1 (en) | 1998-05-13 |
| JPH11514340A (ja) | 1999-12-07 |
| AU5409996A (en) | 1997-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9901186A2 (hu) | Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra | |
| ATE188612T1 (de) | Konjugate von schwach immunogenen antigenen und synthetischen peptidträgern und impfstoffe diese enthaltend | |
| ATE218579T1 (de) | Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin- analogen | |
| GEP20022695B (en) | Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence and Uses Thereof | |
| PT900380E (pt) | Metodos para seleccionar e produzir epitopos peptidicos de celulas t e vacinas que incorporam os referidos epitopos seleccionados | |
| DE69435075D1 (de) | , die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten | |
| ATE418562T1 (de) | Ctl epitope des epstein-barr virus | |
| AU4826493A (en) | Anti-feline immunodeficiency virus (fiv) vaccines | |
| DK0491628T3 (da) | Lipopeptider inducerende cytotoksiske T-lymfocytter og deres anvendelse som vacciner | |
| PT840750E (pt) | Peptido antigenico de ha-2 | |
| GB0203419D0 (en) | Peptide | |
| PT996636E (pt) | Antigenio ha-1 | |
| EP0879244A4 (en) | RECOMBINANT POLYPEPTIDE VACCINE AGAINST MYCOPLASMS. | |
| NO942360L (no) | Vaksine og polypeptider som er nyttige for denne | |
| EP1174439A3 (en) | Compositions and methods for treating infections using analogues of indolicidin | |
| AU4712993A (en) | New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods | |
| AU8976691A (en) | Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof | |
| AU5872594A (en) | Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease | |
| DK0811067T3 (da) | Equin arteritisviruspeptider, antistoffer og deres anvendelse i en diagnostisk test | |
| ATE338063T1 (de) | Diagnostische verwendungen des t-zell proteins tzon7, der davon abgeleiteten peptide und des antikörpers | |
| BR9608837A (pt) | "composição obtida de células para detectar uma infecção por vìrus da imunodeficiência humana, aparelho, kit e métodos para sua detecção, purificação da proteìna e sua obtenção e tratamento do ser humano" | |
| FR2856598A1 (fr) | Peptides derives de la proteine mmp-2 et leur utilisation en immunotherapie antitumorale | |
| ES1027961U (es) | Soporte publicitario para carritos. |